1 Patterns of Drug Use: Methodological Considerations, Measurement Techniques, and Future Trends.- 2 Litigation and the Use of Psychoactive Drugs in Developmental Disabilities.- 3 Psychotropic Drug Blood Levels: Measurement and Relation to Behavioral Outcome in Mentally Retarded Persons.- 4 Neuroleptic Medications for Persons with Developmental Disabilities.- 5 Antiepileptic Drugs.- 6 Other Psychotropic Drugs.- 7 Novel Psychoactive Agents in the Treatment of Developmental Disorders.- 8 Vitamin, Mineral, and Dietary Treatments.- 9 Tardive Dyskinesia and Developmental Disabilities.- 10 Issues in Behavioral Pharmacology: Implications for Developmental Disorders.- 11 Conclusions.- Glossary of Psychotropic Drug Classes, Generic Names, and Trade Names.- Author Index.

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com